NCT06957834View on ClinicalTrials.gov

Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

July 11, 2024

Study Completion Date

July 11, 2024

Conditions

Melasma

Interventions

DRUG

Eflornithine hydrochloride cream

Eflornithine hydrochloride cream at 11.5% applied twice daily

DRUG

Hydroquinone cream

Hydroquinone 2% cream, applied twice daily

Trial Locations (1)

Unknown

National Skin Centre, Singapore

All Listed Sponsors

lead

National Skin Centre

NETWORK

NCT06957834 - Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study | Biotech Hunter | Biotech Hunter